Intelligence Platform
Patents
Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11382989
Engineered microbial population
granted patentUS 11377491
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and
granted patentUS 11376324
Sting activating nanovaccine for immunotherapy
granted patentUS 11369716
Reparative cell isolation and delivery
granted patentUS 11370786
GLS1 inhibitors for treating disease
granted patentUS 11370757
Photocleavable nitroindoline-based crosslinkers
granted patentUS 11365189
Heterocyclic inhibitors of tyrosine kinase
granted patentUS 11365250
Compositions and methods for cancer therapy
granted patentUS 11365413
Inhibition of poly(A) binding protein and the treatment of pain
granted patentUS 11364197
Compositions and methods of making brittle-matrix particles through blister pack freezing
granted patentUS 11365183
Eicosanoid derivatives
granted patentUS 11358991
Heme sequesting peptides and uses therefor
granted patentUS 11344577
Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted patentUS 11344578
Immune cells expressing engineered antigen receptors
granted patentUS 11345659
Pipecolic esters for inhibition of the proteasome
granted patentUS 11332483
Naphthoquinone containing gold carbene complexes and methods of uses thereof
granted patentUS 11331333
Treatment of aberrant fibroblast proliferation
granted patentUS 11325898
Small molecule inducers of autophagy
granted patentUS 11318186
Use of FGF21 in methods of increasing exocrine pancreatic secretion
granted patentUS 11313868
Methods of detecting anti-folic acid antibodies and uses thereof
granted patentUS 11304916
Methods and compositions for the treatment of Shiga Toxicosis
granted patentUS 11304911
Compositions and methods for organ specific delivery of nucleic acids
granted patentUS 11299512
Cyclic di-nucleotide compounds and methods of use
granted patentUS 11293024
Antisense antibacterial compounds and methods
granted